Pioneer in Finding Solutions to Antibiotic Resistance

Pioneer in Solutions to
Antibiotic Resistance

Ravina Kullar



Dr. Ravina Kullar is a pioneer in finding solutions to antibiotic resistance – one of the greatest threats to global health. An infectious diseases global expert and researcher, she has published over 30 research papers and has been invited to participate in the worldwide effort to help tackle this global threat. Her passion for this work stems from personal experiences with patients in her care with infections resistant to almost every antibiotic. These patients should have survived. Dr. Kullar wants to empower everyone in the world to be a part of the solution, by arming them with the information they need to take action.


Post-Doctoral Infectious Diseases Outcomes Pharmacotherapy Fellowship
Wayne State University, Anti-Infective Research Laboratory, 2008-2011

Masters of Public Health (M.P.H) in Biostatistics and Epidemiology,
Wayne State University School of Medicine, 2008-2012

Postgraduate Year-1 (PGY1) Pharmacy Clinical Residency,
Detroit Receiving Hospital, 2007-2008

University of Southern Nevada, Henderson, NV
Doctor of Pharmacy, 2004-2007

As featured on:

Honors & Awards

Invited Keynote Speaker at 72nd World Health Assembly; “Time for Concrete Action: Addressing the Global Antimicrobial Resistance (AMR) crisis”; May 21, 2019; Geneva, Switzerland

Invited TED Speaker; “The Antibiotic Apocalypse: Superbugs vs. Humans”; TEDxSquareMile; 2019

Honored as Fellow of Infectious Diseases Society of America (FIDSA); 2018

Invited TED Speaker; “The Antibiotic Resistance Crisis: How to be a part of the solution;” 2018

Invited TED Speaker; “Understanding the crisis and how you can prevent a future pandemic;” 2018

Awarded as Who’s Who in the World-Albert Nelson Marquis Lifetime Achievement Award; 2018

Invited to United Nations General Assembly Meeting on Antimicrobial Resistance — Forum on Sustainable Access to Effective Antibiotics; 2016

Society of Infectious Diseases (SIDP) Infectious Diseases Impact Paper of the Year; 2011

  • Awarded for paper entitled “Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: Support for consensus guidelines suggested targets” published in Clinical Infectious Diseases
  • The purpose of this prestigious award is to “recognize a significant contribution to the peer-reviewed literature in infectious diseases pharmacotherapy.”

"Antibiotics are the only drug where every time each one of us uses it, it becomes less and less effective not only in us but in others that have not even been exposed to the drug."

Ravina Kullar
Global Infectious Diseases Expert

Affiliations & Philanthropy

Dr. Kullar’s unending passion to truly educate and teach everyone about the consequences of antibiotic resistance is a commitment she not only cherishes but one she carries with her at all times. As a well respected solution expert on what can be done to decrease antibiotic resistance she is a global leader in infectious diseases, trusted by her peers and public alike, in not only being a great researcher but truly wanting to help and leading the fight against antibiotic resistance.

Having run over 10 marathons, she equates long-distance running to the fight against antibiotic resistance. “Just like a marathon,” she says, “the fight against antibiotic resistance isn’t just a race; it’s a journey – a journey that requires us to get past our comfort zones, because that’s when and where the magic starts to happen.” Through her various affiliations and philanthropic work, she continues the journey toward a better tomorrow for all.

  • American College of Clinical Pharmacy (ACCP)
  • American Society of Health-System Pharmacists (ASHP)
  • Association for Professionals in Infection Control and Epidemiology (APIC)
  • Infectious Diseases Association of California (IDAC)
  • Infectious Disease Society of America (IDSA)
  • Los Angeles Department of Public Health
  • Society of Infectious Diseases Pharmacists (SIDP)
  • Partnership Scholars Program

“The future is a place that you get to create. If we work together, we can have a future where antibiotics can still save lives.”

Dr. Ravina Kullar

Selected Publications & Presentations


Kullar R, Johnson S, McFarland LV, Goff DA, Goldstein EJC. Bundling Probiotics with Antimicrobial Stewardship Programs (ASPs) for the Prevention of Clostridiodes difficile Infections (CDI) in Acute Care Hospitals. Infectious Diseases in Clinical Practice March 2020

Kullar R, Goff DA, Gauthier TP, Smith TC. To Tweet or Not to Tweet-A Review of the Viral Power of Twitter for Infectious Diseases. Current Infectious Disease Reports 2020.

McCreary E, Kullar R, et al.  Multicenter Cohort of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia Receiving Daptomycin plus Ceftaroline Compared to Other MRSA Treatments. Open Forum Infect Dis. 2019 Dec 31;7(1):ofz538. DOI: 10.1093/ofid/ofz538

Bauer KA, Kullar R, Gilchrist, M, File TM. Antibiotics and Adverse Events: The Role of Antimicrobial Stewardship Programs in ‘Doing No Harm.’ Curr Opin Infect Dis 2019 Dec; 32(6): 553-558

Goff DA, Kullar R. Can the Perfect Handshake Hold the Key to Success and Sustainability of Antimicrobial Stewardship Programs? Clin Infect Dis 2019 Oct 4. pii: ciz699.

Ha DR, Forte MB, Olans RD, OYong K, Olans RN, Gluckstein DP, Kullar R, Desai M, Catipon N, Ancheta V, Lira D, Khattak Y, Legge J, Nguyen KB, Chan S, Mourani J, McKinnell JA. A Multi-disciplinary Approach to Incorporate Bedside Nurses into Antimicrobial Stewardship and Infection Prevention. Jt Comm J Qual Patient Saf. 2019 Sep; 45(9): 600-605.

Kullar R, Frisenda J, Nassif PS. The More the Merrier? Should Antibiotics be Used for Rhinoplasty and Septorhinoplasty?—A Review. Plastic and Reconstructive Surgery – Global Open. 2018 October; 6(10): e1972.
DOI: 10.1097/GOX.0000000000001972

Kullar R, Nagel J, Bleasdale SC, Sutton SH, Naumovski S, Rodriguez A, Smith C, Leggett J, Goldstein EJC. Going for the Gold: A Description of ‘Centers of Excellence’ Designation by Infectious Diseases Society of America. Clinical Infectious Diseases 2018 Sep 18.
DOI: 10.1093/cid/ciy797

Co-author with National Quality Forum. Antibiotic Stewardship in Post-Acute and Long-Term Care Playbook.

Kullar R, Yang H, Grein J, Murthy R. A Roadmap to Implementing Antimicrobial Stewardship Principles in Long-Term Care Facilities (LTCFs): Collaboration Between an Acute-Care Hospital and LTCFs. Clinical Infectious Diseases 2018 Apr 3;66(8):1304-1312.
DOI: 10.1093/cid/cix1041

Goff DA, Kullar R, Bauer K, File T. Eight Habits of Highly Effective Antimicrobial Stewardship Programs to Meet the Joint Commission Standards for Hospitals. Clinical Infectious Diseases 2017 Apr 15;64(8):1134-1139.
DOI: 10.1093/cid/cix065

Goff DA, Kullar R, Goldstein EJ, Gilchrist M, Nathwani D, Cheng AC, Cairns KA, Escandón-Vargas K, Villegas MV, Brink A, van den Bergh D, Mendelson M. A Global Call From Five Countries to Collaborate in Antibiotic Stewardship: United We Succeed, Divided We Might Fail. Lancet Infectious Diseases 2016 Nov 17.

Goff DA, Kullar R, Newland JG. Review of Twitter for Infectious Diseases Clinicians: Useful or a Waste of Time? Clinical Infectious Diseases 2015 May 15; 60 (10): 1533-40.

Forrest GN, Van Schooneveld TC, Kullar R, Schulz LT, Duong P, Postelnick M. Use of Electronic Health Records and Clinical Decision Support Systems for Antimicrobial Stewardship. Clinical Infectious Diseases 2014 Oct 15;59 Suppl 3:S122-33.
DOI: 10.1093/cid/ciu565

Kullar R, Goff D.A. Transformation of Antimicrobial Stewardship Programs through Technology. Infectious Disease Clinics of North America 2014 Jun; 28(20): 291-300.
DOI: 10.1016/j.idc.2014.01.009

Kullar R, Goff D.A., Schulz LT, Fox B.C., Rose W.E. The “Epic” Challenge of Optimizing Antimicrobial Stewardship: the Role of Electronic Medical Records and Technology. Clinical Infectious Diseases 2013 Oct; 57(7): 1005-13.
DOI: 10.1093/cid/cit318


Kullar R. Coronavirus. Invited Expert on Entertainment Today. March 2, 2020.

Kullar R. Coronavirus. Invited Podcast Infectious Diseases Society of America (IDSA). February 28, 2020.

Kullar R., Goldstein EJC. Handling Outbreaks in Long-Term Care Facilities (LTCFs). Invited SHEA Podcast December 2019.

Kullar R. Becoming a Steward in Long-Term Care Facilities; Invited Speaker for MAD-ID Online Antimicrobial Stewardship (AMS) Teaching Modules; November 2018.

Kullar R. The Antibiotic Resistance Crisis: How to be a part of the solution; Invited TED Speaker; September 26, 2018; Detroit, MI

Kullar R. Antibiotic Resistance: Understanding the crisis and how you can prevent a future pandemic; Invited TED Speaker; March 31, 2018; Bend, OR

Kullar R. Invited speaker for Infectious Diseases Association for California (IDAC). How to Meet The Joint Commission (TJC) 8 Antimicrobial Stewardship Standards. Berkeley, CA; March 3, 2018.

Kullar R. Invited speaker for Los Angeles Department of Public Health – Antibiotics Awareness Week. Meeting The Joint Commission 8 Antimicrobial Stewardship Standards and Overcoming Common Barriers in Your Stewardship Program. Los Angeles, CA; November 13, 2017.

Kullar R. Invited speaker for Infectious Diseases Association for California (IDAC). Components of an Effective ASP Informatics Program: Essential Elements and Helpful Enhancements. Berkeley, CA; March 4, 2016.

Kullar R. Invited speaker for Infectious Diseases Association for California (IDAC). Components of an Effective ASP Informatics Program: Essential Elements and Helpful Enhancements. Irvine, CA; July 18, 2015.

Contact Dr. Ravina Kullar

Contact Dr. Ravina Kullar